Loading clinical trials...

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients | Clinical Trials | Clareo Health

COMPLETEDPhase 3NCT00571649

Venous Thromboembolic Event (VTE) Prophylaxis in Medically Ill Patients

This study will evaluate if extended therapy with oral rivaroxaban can prevent blood clots in the leg and lung that can occur with patients hospitalized for acute medical illness, and compare these re...

Lead sponsor: Bayer•121 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGNA

CLEANer Aspiration for Pulmonary Embolism

NCT06189313 · Pulmonary Embolism, Acute Pulmonary Embolism, and more

RECRUITINGPhase 3

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

NCT07015905 · Venous Thromboembolism (VTE)

RECRUITINGNA

Computerized Decision Support for Prevention of VTE in Hospitalized Medical Patients Across the Continuum of Care (DC-eALERT)

NCT03728166 · Venous Thromboembolism

RECRUITINGPhase 3

Reducing Gastrointestinal Bleeding With Proton Pump Inhibitor Therapy in Acute Venous Thromboembolism

NCT06393868 · Venous Thromboembolism, Gastro Intestinal Bleeding, and more

RECRUITINGPhase 2

A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

NCT07140523 · Venous Thromboembolism

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: September 15, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment8,101

Start dateDec 2007

Last updatedSep 15, 2016

Condition

Venous Thromboembolism

Locations shown

Birmingham, Alabama

Dothan, Alabama

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 15, 2016Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions